Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Patient characteristics
Characteristics Data
Patients enrolled N = 43
Age (mean) 70.5 ± 14
Male sex (%) 27 (63%)
Hypertension 61%
Hyperlipidemia 38%
Diabetes mellitus 24%
Coronary heart disease 42%
NIHSS score (median) (IQR) 15 (11–18) 
Time from admission to procedure (median) (IQR) 59 (29–113)
mRS <2 at 3 months 27%
CT angiography before procedure 37
MCA (M1 segment) occlusion 26
MCA (M2 segment) occlusion 4
Intracranical internal carotid artery occlusion 2
Posterior cerebral artery occlusion 1
Basilar artery occlusion 7
Endovascular procedures 
Angioplasty 12
Intra-arterial thrombolysis 4
Mechanical embolectomy (Solitaire)^a 1
Stenting (Wingspan)^b 22
Combined therapy (IVT + endovascular procedures) 22


↵a ev3, Irvine, California.

 
↵b Boston Scientific, Natick, Massachusetts.

Characteristics	Data
Patients enrolled	N = 43
Age (mean)	70.5 ± 14
Male sex (%)	27 (63%)
Hypertension	61%
Hyperlipidemia	38%
Diabetes mellitus	24%
Coronary heart disease	42%
NIHSS score (median) (IQR)	15 (11–18)
Time from admission to procedure (median) (IQR)	59 (29–113)
mRS <2 at 3 months	27%
CT angiography before procedure	37
MCA (M1 segment) occlusion	26
MCA (M2 segment) occlusion	4
Intracranical internal carotid artery occlusion	2
Posterior cerebral artery occlusion	1
Basilar artery occlusion	7
Endovascular procedures
Angioplasty	12
Intra-arterial thrombolysis	4
Mechanical embolectomy (Solitaire)^a	1
Stenting (Wingspan)^b	22
Combined therapy (IVT + endovascular procedures)	22